Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : World Heart Corp - WHRT and TSE/WHT -- Ignore unavailable to you. Want to Upgrade?

To: Dan Hamilton who wrote (140)	11/13/1998 2:12:00 PM
From: the Chief	Respond to of 500

"this isn't a widows and orphans stock". I've had plenty of time to think about this statement! It's true.....but, what BioMed in R&D isn't??? Remember, as a minimum, we can keep sick calves alive! There could be a market for that!!!!!!!!!<hahahahahaha!> the Chief

To: Dan Hamilton who wrote (140)	11/16/1998 4:21:00 PM
From: the Chief	Respond to of 500

Hi Dan. There was two articles in the Ottawa Citizen today. One playing up the "communications system" (TET)that will be demonstrated in Dusseldorf, the other, just a typical article on the risks associated with this type of stock. They pointed out risk/reward...but the jist of the article was the risk, not specifically WHT, they just mentioned it!! Dusseldorf, here we come!!! The best is yet too come!!! the Chief

To: Dan Hamilton who wrote (140)	11/21/1998 11:00:00 AM
From: the Chief	Respond to of 500

World Heart picks up the pace Ottawa company monitors, controls device via telephone Karyn Standen The Ottawa Citizen In what it considers the first demonstration of its kind in medical history, World Heart Corp. yesterday showed that its artificial heart-assist device can be remotely monitored and altered across great distances. "The implication for health care is huge," said Dr. Tofy Mussivand, president of World Heart Corp., and head of the development team that created HeartSaver, the company's artificial heart assist device. "The gate is now open for having a device within a patient's body remotely monitored in real time. Intervention can be implemented in seconds, meaning patients have access to hospitals without having to go to the hospital." World Heart is not the only company to have developed an artificial heart-assist device. A U.S. company earlier this month implanted its artificial heart assist device in two European patients. (HeartSaver is expected to begin human trials next year). Yet a Montreal analyst says it is likely World Heart is the first to prove it can remotely monitor such a device. "I don't believe any other public company has done this," Jean-Luc Berger, an analyst with Credifinance Securities Ltd. said in reference to HeartSaver's long-distance demonstration. HeartSaver is a left-ventricular assist device that can be implanted in a patient's chest cavity for permanent use or temporarily until a transplant organ becomes available. It uses a wireless biotelemetry system to send power and digital data through the skin, meaning there are no openings in the body that can lead to infection. World Heart has in the past shown how a technician near a HeartSaver model can monitor and alter its beat after it isinstalled in a test dummy. Yesterday's demonstration was unique, however, in that the commands to control the artificial heart assist device located in Ottawa came from Germany. "We're moving into the final 12 months before human trials (of HeartSaver)," said World Heart chief executive Rod Bryden. "This demonstration is another sign that (HeartSaver) is moving at the planned pace of development." World Heart is showcasing HeartSaver at the Medica Conference, the largest medical-devices trade show in the world. The conference, in Dusseldorf, Germany, is expected to attract 110,000 visitors. In yesterday's demonstration, a HeartSaver device was linked via telephone to the laptop computer of a World Heart employee attending the conference. By keying commands into the computer, the employee in Germany instructed HeartSaver to increase its beat to 100 from 50 beats per minute. The command was carried out within about 20 seconds. While information relating to HeartSaver's status and commands to change its beat were issued through a telephone line, Dr. Mussivand said the device can also be controlled through satellite and fibre-optic transmission systems. "The coupling of this technology is tremendous," Dr. Keon said after the demonstration. "In addition to artificial hearts, you will be able to monitor pacemakers and patients with metabolic diseases like diabetes." "The convergence of this technology drastically reduces the cost of health care and lets people travel freely." Kevin Holmes, World Heart's department head of scientific publications and one of the employees at the conference, said visitors to the trade show are impressed with HeartSaver. "People are describing (HeartSaver) as amazing," he said, adding several asked when the device will be ready for clinical trials. Production of the HeartSaver device is slated to begin in 2000. World Heart is projecting its first profit, of about $13million U.S., in 2001. World Heart's shares, which trade on the Toronto Stock Exchange, yesterday fell five cents to close at $12.70. Wahoooooooooooooooooo....well done Worldheart!!! the Chief

To: Dan Hamilton who wrote (140)	12/16/1998 2:38:00 PM
From: the Chief	Read Replies (2) \| Respond to of 500

Nasdaq listing upgraded World Heart Corp WHT Shares issued 12,243,000 Dec 15 close $12.25 Wed 16 Dec 98 News Release Mr. Ian Malone reports The company's common shares have been approved for listing on the Nasdaq National Market under the symbol WHRTF. The upgrading of the company's Nasdaq listing from Smallcap to National Market status is expected to result in increased liquidity for the company's U.S. shareholders. (c) Copyright 1998 Canjex Publishing Ltd. canada-stockwatch.com